Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL)

被引:21
|
作者
Mocciaro, Gabriele [1 ,2 ]
Allison, Michael [3 ]
Jenkins, Benjamin [4 ]
Azzu, Vian [3 ,4 ]
Huang-Doran, Isabel [3 ]
Herrera-Marcos, Luis Vicente [5 ]
Hall, Zoe [6 ]
Murgia, Antonio [1 ,4 ]
Susan, Davies [3 ,4 ]
Frontini, Mattia [7 ]
Vidal-Puig, Antonio
Koulman, Albert [4 ]
Griff, Julian L. [1 ,8 ]
Vacca, Michele [1 ,2 ,4 ,9 ,10 ]
机构
[1] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England
[2] Fdn Liver Res, Roger Williams Inst Hepatol, London SE5 9NT, England
[3] Addenbrookes Hosp, Cambridge Biomed Res Ctr, Dept Med, Cambridge, England
[4] Wellcome Trust MRC Inst Metab Sci, Metab Res Labs, Cambridge CB2 0QQ, England
[5] Univ Zaragoza, Vet Fac, Dept Biochem & Mol & Cellular Biol, Zaragoza 50013, Spain
[6] Imperial Coll London, Dept Metab Digest & Reprod, Div Syst Med, Biomol Med, London SW7 2AZ, England
[7] Univ Exeter, Fac Hlth & Life Sci, Clin & Biomed Sci, Med Sch, RILD Bldg,Barrack Rd, Exeter EX2 5DW, England
[8] Univ Aberdeen, Rowett Inst, Foresterhill Campus, Aberdeen AB25 2ZD, Scotland
[9] Aldo Moro Univ Bari, Dept Interdisciplinary Med, Clin Med C Frugoni, I-70124 Bari, Italy
[10] Aldo Moro Univ Bari, Dept Interdisciplinary Med, Clin Med C Frugoni, I-70124 Bari, Italy
来源
MOLECULAR METABOLISM | 2023年 / 73卷
基金
英国医学研究理事会;
关键词
Non-alcoholic fatty liver disease (NAFLD); Obesity; Lipoprotein metabolism; Lipidomics; LC-MS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; CHOLESTEROL EFFLUX; HEPATIC STEATOSIS; SCORING SYSTEM; METABOLISM; MARKERS; PHOSPHATIDYLCHOLINE; TRIACYLGLYCEROL; SPHINGOMYELIN;
D O I
10.1016/j.molmet.2023.101728
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: Non-alcoholic fatty liver disease (NAFLD) develops due to impaired hepatic lipid fluxes and is a risk factor for chronic liver disease and atherosclerosis. Lipidomic studies consistently reported characteristic hepatic/VLDL "lipid signatures" in NAFLD; whole plasma traits are more debated. Surprisingly, the HDL lipid composition by mass spectrometry has not been characterised across the NAFLD spectrum, despite HDL being a possible source of hepatic lipids delivered from peripheral tissues alongside free fatty acids (FFA). This study characterises the HDL lipidomic signature in NAFLD, and its correlation with metabolic and liver disease markers.Methods: We used liquid chromatography-mass spectrometry to determine the whole serum and HDL lipidomic profile in 89 biopsy-proven NAFLD patients and 20 sex and age-matched controls. Results: In the whole serum of NAFLD versus controls, we report a depletion in polyunsaturated (PUFA) phospholipids (PL) and FFA; with PUFA PL being also lower in HDL, and negatively correlated with BMI, insulin resistance, triglycerides, and hepatocyte ballooning. In the HDL of the NAFLD group we also describe higher saturated ceramides, which positively correlate with insulin resistance and transaminases.Conclusion: NAFLD features lower serum lipid species containing polyunsaturated fatty acids; the most affected lipid fractions are FFA and (HDL) phospholipids; our data suggest a possible defect in the transfer of PUFA from peripheral tissues to the liver in NAFLD. Mechanistic studies are required to explore the biological implications of our findings addressing if HDL composition can influence liver metabolism and damage, thus contributing to NAFLD pathophysiology.(c) 2023 Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease
    Di Minno, Matteo Nicola Dario
    Russolillo, Anna
    Lupoli, Roberta
    Ambrosino, Pasquale
    Di Minno, Alessandro
    Tarantino, Giovanni
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (41) : 5839 - 5847
  • [32] Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease
    Matteo Nicola Dario Di Minno
    Anna Russolillo
    Roberta Lupoli
    Pasquale Ambrosino
    Alessandro Di Minno
    Giovanni Tarantino
    World Journal of Gastroenterology, 2012, (41) : 5839 - 5847
  • [33] Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease
    Prahlad K. Rao
    Kate Merath
    Eugene Drigalenko
    Avinash Y. L. Jadhav
    Richard A. Komorowski
    Matthew I. Goldblatt
    Anand Rohatgi
    Mark A. Sarzynski
    Samer Gawrieh
    Michael Olivier
    Clinical Proteomics, 2018, 15
  • [34] Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease
    Rao, Prahlad K.
    Merath, Kate
    Drigalenko, Eugene
    Jadhav, Avinash Y. L.
    Komorowski, Richard A.
    Goldblatt, Matthew I.
    Rohatgi, Anand
    Sarzynski, Mark A.
    Gawrieh, Samer
    Olivier, Michael
    CLINICAL PROTEOMICS, 2018, 15
  • [35] Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring
    Long, Michelle T.
    Gurary, Ellen B.
    Massaro, Joseph M.
    Ma, Jiantao
    Hoffmann, Udo
    Chung, Raymond T.
    Benjamin, Emelia J.
    Loomba, Rohit
    LIVER INTERNATIONAL, 2019, 39 (04) : 740 - 747
  • [36] Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
    Valenzuela-Vallejo, Laura
    Sanoudou, Despina
    Mantzoros, Christos S.
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (05):
  • [37] Low concentrations of serum n-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease patients with liver injury
    Kishino, Tomonori
    Ohnishi, Hiroaki
    Ohtsuka, Kouki
    Matsushima, Satsuki
    Urata, Tsuyoshi
    Watanebe, Keiko
    Honda, Yukihisa
    Mine, Yoshitake
    Matsumoto, Motoko
    Nishikawa, Kaori
    Mori, Hideaki
    Takahashi, Shin'ichi
    Ishida, Hitoshi
    Watanabe, Takashi
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (01) : 159 - 162
  • [38] Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis
    Orlando, R.
    Azzalini, L.
    Orando, S.
    Lirussi, F.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):
  • [39] Bile acids and sphingolipids in non-alcoholic fatty liver disease
    Jackson Kaitlyn G.
    Way Grayson W.
    Zhou Huiping
    中华医学杂志英文版, 2022, 135 (10) : 1163 - 1171
  • [40] Bile acids and sphingolipids in non-alcoholic fatty liver disease
    Jackson, Kaitlyn G.
    Way, Grayson W.
    Zhou, Huiping
    CHINESE MEDICAL JOURNAL, 2022, 135 (10) : 1163 - 1171